business / news / / Seeking Alpha
Bristol-Myers posts Q1 beat thanks to growth portfolio.
Bristol-Myers Squibb reported better-than-expected Q1 2026 financials.
KEY POINTS
- Growth portfolio performance offset declining demand for legacy products.
- The company recorded $11.5 billion in revenue for the quarter.
- BMY shares traded higher in premarket following the earnings report.
COMPANIES
Summarized by Newsio from Seeking Alpha. How we summarize →